Skip to content

Regulus Therapeutics Inc.: filings

Every Regulus Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-05-08fiscal Q1 202538800001628280-25-023872
10-K2025-03-13fiscal FY 202447960001628280-25-012627
10-Q2024-11-07fiscal Q3 2024391160001628280-24-046316
10-Q2024-08-08fiscal Q2 2024401140001628280-24-036174
10-Q2024-05-09fiscal Q1 202438800001628280-24-022266
10-K2024-03-21fiscal FY 202347960001628280-24-012543
10-Q2023-11-09fiscal Q3 2023391160001628280-23-038295
10-Q2023-08-08fiscal Q2 2023391120001628280-23-028240
10-Q2023-05-11fiscal Q1 202339820001628280-23-017587
10-K2023-03-23fiscal FY 2022491000001628280-23-009061
10-Q2022-11-14fiscal Q3 2022411200001628280-22-029546
10-Q2022-08-11fiscal Q2 2022411160001628280-22-022505
10-Q2022-05-13fiscal Q1 202239820001628280-22-014165
10-K2022-03-11fiscal FY 202148970001628280-22-005771
10-Q2021-11-12fiscal Q3 2021391160001628280-21-022902
10-Q2021-08-10fiscal Q2 2021391120001628280-21-016431
10-Q2021-05-14fiscal Q1 202134720001628280-21-010200
10-K2021-03-09fiscal FY 2020441120001628280-21-004294
10-Q2020-11-05fiscal Q3 2020361020001628280-20-015789
10-Q2020-08-13fiscal Q2 202035960001628280-20-012643
10-Q2020-05-14fiscal Q1 202034710001628280-20-007809
10-K2020-03-12fiscal FY 2019441120001628280-20-003483
10-Q2019-11-12fiscal Q3 2019381080001628280-19-013991
10-Q2019-08-08fiscal Q2 201935980001628280-19-010478
10-Q2019-05-10fiscal Q1 201935720001628280-19-006483
10-K2019-03-18fiscal FY 2018431370001628280-19-003037
10-Q2018-11-09fiscal Q3 201834910001628280-18-014023
10-Q2018-08-09fiscal Q2 201833890001628280-18-010974
10-Q2018-05-10fiscal Q1 201833690001628280-18-006555
10-K2018-03-08fiscal FY 2017431370001628280-18-002874
10-Q2017-11-08fiscal Q3 201734900001628280-17-011106
10-Q2017-08-02fiscal Q2 201734900001628280-17-007796
10-Q2017-05-05fiscal Q1 201734700001628280-17-004992
10-K2017-03-03fiscal FY 2016431370001628280-17-002123
10-Q2016-11-02fiscal Q3 201634900001628280-16-020579
10-Q2016-08-03fiscal Q2 201634900001628280-16-018315
10-Q2016-05-03fiscal Q1 201633680001628280-16-015293
10-K2016-02-23fiscal FY 2015431390001628280-16-011521
10-Q2015-11-06fiscal Q3 2015351000001628280-15-008379
10-Q2015-08-05fiscal Q2 201535990001193125-15-276880
10-Q2015-05-08fiscal Q1 201531640001193125-15-177520
10-K2015-02-19fiscal FY 2014401390001193125-15-052948
10-Q2014-11-06fiscal Q3 2014361010001193125-14-398921
10-Q2014-08-07fiscal Q2 2014371020001193125-14-298602
10-Q2014-05-09fiscal Q1 201436720001193125-14-190461
10-K2014-02-28fiscal FY 2013431400001193125-14-074001
10-Q2013-11-14fiscal Q3 2013411120001193125-13-440494
10-Q/A2013-08-16fiscal Q2 201337950001193125-13-337013
10-Q2013-08-14fiscal Q2 201337950001193125-13-333123
10-Q2013-05-15fiscal Q1 201337740001193125-13-220102
10-K2013-02-19fiscal FY 2012411280001193125-13-065164
10-Q2012-11-19fiscal Q3 201234900001193125-12-475602

Inspect the source

Entity
Regulus Therapeutics Inc. / CIK 0001505512
Captured
2026-09-21T17:19:33.288Z
SEC response SHA-256
d48711811ca317266f22b6dd9aef915292bbf4d32d492a9ca0f457fe5ac78c2d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505512.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))